AAV-ADDL mab (BGF72) WT Cas9-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR646)

The product is a highly efficient, inducible WT Cas9-ASGR1 gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-ADDL mab (BGF72) in Human B cell engineering.

Datasheet

Specifications

Clone BGF72
Host Humanized
Packaging Cell Line CHO-GS
Vector Promoter EF1a
Rep Rep68
Capsid VP3
Envelope Env
Matrix N-terminal
Size ~7kb
Genome dsDNA
Virus Type AAV
Cofactor Requirement No dNTPs
Particles/mL 4.9 × 10¹¹
PFU/mL 2.2 × 10¹¹
TU/mL 9.6 × 10¹¹
Cas9 WT Cas9
sgRNA ASGR1
Engineered B Cell Human B cells

Target Information

Target ADDL
Alternative Names ADDL; Amyloid beta-derived diffusible ligands
Gene ID 120(Human)
UniProt ID Q9UEY8(Human)

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products